Specifically, 53 ASEs were differentially included between ERα+ and ERα- BC samples, 72 between BC and normal samples, and 15 between ERα+ BC samples characterized by high or low ERα mRNA levels (Figure 4b and Supplementary Materials Table S7f). The gene discussed is ESR1; the disease is breast cancer.